These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

912 related articles for article (PubMed ID: 31180396)

  • 61. Dual Stimuli-Responsive Polymer Prodrugs Quantitatively Loaded by Nanoparticles for Enhanced Cellular Internalization and Triggered Drug Release.
    Huang M; Zhao K; Wang L; Lin S; Li J; Chen J; Zhao C; Ge Z
    ACS Appl Mater Interfaces; 2016 May; 8(18):11226-36. PubMed ID: 27100328
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
    Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z
    Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534
    [TBL] [Abstract][Full Text] [Related]  

  • 63. pH-sensitive doxorubicin-conjugated prodrug micelles with charge-conversion for cancer therapy.
    Ma B; Zhuang W; Wang Y; Luo R; Wang Y
    Acta Biomater; 2018 Apr; 70():186-196. PubMed ID: 29452272
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Biodegradation and Toxicity of Protease/Redox/pH Stimuli-Responsive PEGlated PMAA Nanohydrogels for Targeting Drug delivery.
    Jin S; Wan J; Meng L; Huang X; Guo J; Liu L; Wang C
    ACS Appl Mater Interfaces; 2015 Sep; 7(35):19843-52. PubMed ID: 26288386
    [TBL] [Abstract][Full Text] [Related]  

  • 65. pH-sensitive micelles self-assembled from polymer brush (PAE-
    Huang X; Liao W; Zhang G; Kang S; Zhang CY
    Int J Nanomedicine; 2017; 12():2215-2226. PubMed ID: 28356738
    [TBL] [Abstract][Full Text] [Related]  

  • 66.
    Dong Y; Du P; Liu P
    Int J Pharm; 2020 Oct; 588():119723. PubMed ID: 32755688
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sequential release of autophagy inhibitor and chemotherapeutic drug with polymeric delivery system for oral squamous cell carcinoma therapy.
    Saiyin W; Wang D; Li L; Zhu L; Liu B; Sheng L; Li Y; Zhu B; Mao L; Li G; Zhu X
    Mol Pharm; 2014 May; 11(5):1662-75. PubMed ID: 24666011
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer.
    Yang T; Lan Y; Cao M; Ma X; Cao A; Sun Y; Yang J; Li L; Liu Y
    Colloids Surf B Biointerfaces; 2019 Mar; 175():106-115. PubMed ID: 30529816
    [TBL] [Abstract][Full Text] [Related]  

  • 69. pH and Reduction Dual-Responsive Nanogels as Smart Nanocarriers to Resist Doxorubicin Aggregation.
    Maruf A; Milewska M; Lalik A; Wandzik I
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144713
    [TBL] [Abstract][Full Text] [Related]  

  • 70. pH/Reduction Dual-Triggered Degradable Poly(doxorubicin) Prodrug Nanoparticles for Leakage-Free Tumor-Specific Self-Delivery.
    Li J; Liu P
    Macromol Rapid Commun; 2018 Sep; 39(18):e1800381. PubMed ID: 30073742
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A bio-responsive 6-mercaptopurine/doxorubicin based "Click Chemistry" polymeric prodrug for cancer therapy.
    Liao J; Peng H; Wei X; Song Y; Liu C; Li D; Yin Y; Xiong X; Zheng H; Wang Q
    Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110461. PubMed ID: 31924029
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy.
    Jiang Y; Zhou Y; Zhang CY; Fang T
    Int J Nanomedicine; 2020; 15():3319-3331. PubMed ID: 32494132
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
    Xiong S; Wang Z; Liu J; Deng X; Xiong R; Cao X; Xie Z; Lei X; Chen Y; Tang G
    Colloids Surf B Biointerfaces; 2019 Jan; 173():346-355. PubMed ID: 30316081
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of non-covalent interactions in anticancer drug loading and kinetic stability of polymeric micelles.
    Yang C; Attia AB; Tan JP; Ke X; Gao S; Hedrick JL; Yang YY
    Biomaterials; 2012 Apr; 33(10):2971-9. PubMed ID: 22244697
    [TBL] [Abstract][Full Text] [Related]  

  • 75. pH/Reductant Dual-Responsive Core-Cross-Linked Micelles via Facile in Situ ATRP for Tumor-Targeted Delivery of Anticancer Drug with Enhanced Anticancer Efficiency.
    Tian K; Jia X; Zhao X; Liu P
    Mol Pharm; 2016 Aug; 13(8):2683-90. PubMed ID: 27379461
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
    Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
    J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
    [TBL] [Abstract][Full Text] [Related]  

  • 77. pH and redox dual-responsive biodegradable polymeric micelles with high drug loading for effective anticancer drug delivery.
    Teo JY; Chin W; Ke X; Gao S; Liu S; Cheng W; Hedrick JL; Yang YY
    Nanomedicine; 2017 Feb; 13(2):431-442. PubMed ID: 27720991
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Exogenous Vitamin C-Triggered Surface Charge Conversion of pH/Reduction-Responsive Micelles for the Enhanced Tumor-Specific Activity of Loaded Doxorubicin.
    Wu Z; Chen B; Gan Z; Chen F; Luo X
    Mol Pharm; 2020 Mar; 17(3):954-964. PubMed ID: 31977226
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tumor Microenvironment Stimuli-Responsive Polymeric Prodrug Micelles for Improved Cancer Therapy.
    Zhang Z; Yu M; An T; Yang J; Zou M; Zhai Y; Sun W; Cheng G
    Pharm Res; 2019 Dec; 37(1):4. PubMed ID: 31823030
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An Integrated Tumor Microenvironment Responsive Polymeric Micelle for Smart Drug Delivery and Effective Drug Release.
    Zhang N; Liu W; Dong Z; Yin Y; Luo J; Lu T; Tang W; Wang Y; Han Y
    Bioconjug Chem; 2021 Sep; 32(9):2083-2094. PubMed ID: 34472841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.